$32.57
At close: Sep 1, 5:00 PM EST
$32.79
0.220.68%
After Hours: Aug 25, 9:25 AM EST

Quince Therapeutics (QNCX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-16.56 | $-37.40 | $-42.00 | $-42.00 |
| Actual | $-12.31 | $-90.00 | $-152.00 | $-50.00 |
| Surprise | +25.7% | -140.6% | -261.9% | -19.1% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-1.05 | $-0.83 |
| Revenue | ||
| Consensus | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-12.31 | $-16.56 | 25.7 % |
| Q1 | May 11, 2026 | $-90.00 | $-37.40 | -140.6 % |
| Q4 | Apr 10, 2026 | $-152.00 | $-42.00 | -261.9 % |
| Q3 | Nov 12, 2025 | $-50.00 | $-42.00 | -19.1 % |